LRRK2 and Cognitive impairment: Several studies and reviews suggest that LRRK2 mutations are associated with a more benign disease course, less severe clinical symptoms (Nichols et al., 2005), lower risk of cognitive impairment and better cognitive performance (Healy et al., 2008; Srivatsal et al., 2015; Kasten et al., 2017).